Drug Topics publishes only print or online content that is not commercial or promotional in nature and that has not been published elsewhere. In the interest of transparency, Drug Topics will, as necessary, ask authors and sources to provide disclosures or conflict-of-interest statements, which will be published as appropriate to further the cause of information service to the pharmacy community.

One place in our magazine where your article might be used is as a regular news story, such as coverage of a clinical meeting. Freelancers who are covering a meeting must contact the Editor first to ascertain interest.

Another venue is "Viewpoint," which consists of guest editorials written by pharmacists who have strong views on a given pharmacy-related subject. These commentaries should be 600-650 words long and should be accompanied by a color head shot of the author. (The photo should be in .jpg format, 300 dpi resolution or higher.) We make no guarantees of publication; contact the Editor first to ascertain interest.

Finally, you can express your views in the form of a letter to the Editor, which will be considered for publication on our Letters page. Letters should be concise. Please include your name, title, city/state, e-mail address, and date of the issue you are referencing. We will not consider letters without this information. Please send letters to:

Julia Talsma, Editor-in-Chief
Drug Topics
Advanstar Communications
24950 Country Club Blvd., Suite 200
North Olmsted, Ohio 44070

E-mail address: jtalsma@advanstar.com

Correspondence may be edited for length and clarity.

We provide payment only for articles we have commissioned. There is no remuneration for unsolicited submissions, such as Viewpoint.

We are a general newsmagazine; we are not a peer-reviewed journal. If your article is a scholarly paper on a highly technical subject, accompanied by footnotes and citations, it will not be appropriate for our publication.

Electronic submissions are preferred. Please submit electronic submissions to juliatalsma@advanstar.com